Datafoundry, a data science and AI company with comprehensive Safety Platform technology, is delighted to announce a strategic partnership with Oviya MedSafe, A Global Pharmacovigilance Consulting & Drug Safety Services Company. This collaboration aims to revolutionize the efficiency and effectiveness of pharmacovigilance operations by integrating advanced AI automation and digitalization technologies.
Partnership Overview
The partnership between Datafoundry and Oviya MedSafe will leverage Datafoundry’s DF mSafety AI platform to enhance Oviya MedSafe’s robust pharmacovigilance and drug safety services. This collaboration aims to streamline data processes, improve regulatory compliance, and deliver superior safety outcomes for pharmaceutical products.
“We are excited to partner with Oviya MedSafe, a leader in pharmacovigilance and drug safety,” said Mr. Vivek Kalagara, CEO of Datafoundry.
“Oviya MedSafe is delighted to join forces with Datafoundry,” said Dr. J. Vijay Venkatraman, CEO of Oviya MedSafe. “This partnership will allow us to harness the power of AI and data digitalization to further our mission of providing comprehensive drug safety services to pharmaceutical companies worldwide.”